Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Postural Motor Learning Deficits in People With MS in Spatial but Not Temporal Control of Center of Mass.
Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.
Isolation of highly enriched primary human microglia for functional studies.
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
The therapeutic use of cannabinoids: Forensic aspects.
Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors.
Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis.
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
Multiple Sclerosis: Association with the Interleukin-1Gene family Polymorphisms in the Turkish Population.
Relapsing MS patients more satisfied with Novartis oral drug Gilenya(TM) than standard injectable therapies, according to new study results at CMSC
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.
Clinical and MRI phenotype of children with MOG antibodies.
Pages
« first
‹ previous
…
595
596
597
598
599
600
601
602
603
…
next ›
last »